RE:Consistent GrowthHighly unlikely Protech and VieMed will ever merge! They just spent a lot of dollars separating and the two management teams have different priorities on where to focus and invest the available dollars. Each will do fine on their own as both have tons of growth opportunity which will keep each company busy for many years. As such, why merge? As for VMD growing at 30% annually, I think that rate will be sustainable for awhile but it will become more challenging as the company being larger. Last year, the growth rate was around 39%. If they can maintain a 7% quarterly rate, the annualized rate is 31%. The VA deal is however the most significant business arrangement the company can execute on. This business arrangement would further minimize the potential impact of a competitive bidding process and open up a huge market for VMD (market potential of 500,000 additional patients - VMD only has about 6000 patients today. So clearly the VA arrangement would be a game changer and have a significant impact on VMDs valuation. Listen to the last conference call - Casey is very confident they will be able to enter this market soon. Make your own investment decisions, but I see the upside with VMD being huge. As for Protech, I`m more confident Crawford has gone past some learning lessons and he will grow the company over time (likely not as fast as he originally provided guidance (I believe he guided for $100 million at the end of 2018).